Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hungerford Brian Insider Profile
4 Followers
Hungerford Brian, CFO at Kiromic Biopharma, holds 64.93K shares in Kiromic Biopharma (Ticker: KRBP). Most recently, Hungerford Brian Bought $4,000 shares of Kiromic Biopharma on Aug 21, 2024 for an estimated value of 8.78K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-34.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Hungerford Brian's holdings
Insider Roles
CFO
Roles that Hungerford Brian holds in companies
Most Profitable Insider Trade
The most profitable trade made by Hungerford Brian
Hungerford Brian's Trading History
List of latest transactions for each holding click on a transaction to see Hungerford Brian's performance on stock
You May Also Like
Hungerford Brian insider profile FAQ
What is the percentage of profitable transactions made by Hungerford Brian?
The percentage of profitable transactions made by Hungerford Brian is 0%.
What is the average return per transaction made by Hungerford Brian?
The average return per transaction made by Hungerford Brian is -34.90%.
What stocks does Hungerford Brian hold?
Hungerford Brian holds: KRBP stocks.
What was Hungerford Brian’s latest transaction?
Hungerford Brian latest transaction was an Informative Buy of $8.78K.
What was Hungerford Brian's most profitable transaction?
Hungerford Brian’s most profitable transaction was an Informative Buy of KRBP stock on August 14, 2024. The return on the trade was -18.80%.
What is Hungerford Brian's role in Kiromic Biopharma?
Hungerford Brian's role in Kiromic Biopharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.